• Home

Related articles

  • Oropharyngeal Carcinomas: the UICC/AJCC TNM Staging System, 8th Edition

    S Huang

  • HPV attributable fractions and trends in head and neck carcinomas

    L Alemany, M Mena

  • Clinical management of HPV-related recurrent/metastatic (R/M) oropharyngeal cancer patients

    M Taberna, R Mesia, RL Ferris

  • Will HPV vaccines reduce oropharyngeal cancer burden?

    A Kreimer, A Chaturvedi

  • Screening for HPV-Driven Oropharyngeal Cancer

    AR Kreimer, T Waterboer.

  • Counseling patients with HPV-positive oropharyngeal cancer

    M Windon, E Rettig

  • Interview to Barbara Moscicki

    AB Moscicki

  • Anal HPV infection: risk groups and natural history

    EA Stier

  • One dose: a great public health intervention?

    J J Kim

  • FACT SHEET: ITALY www.hpvcentre.net

    P. Lopalco, G. Albero, L. Bruni

  • Elimination of HPV from different countries

    I Baussano

  • FACT SHEET: UNITED KINGDOM www.hpvcentre.net

    C Gilham, G Albero, L Bruni

  • FACT SHEET: UNITED STATES OF AMERICA www.hpvcentre.net

    P. Gravitt, G. Albero, L. Bruni

  • The Biological Rationale For A One Dose HPV Vaccine

    J T Schiller

  • FACT SHEET: PORTUGAL www.hpvcentre.net

    R. Medeiros, G. Albero, L. Bruni

  • Trends in the incidence of vulvar and vaginal cancers

    F Bray

  • Interview with Jacob Bornstein 2

    J Bornstein

  • FACT SHEET: JAPAN www.hpvcentre.net

    R Konno, G Albero, L Bruni

  • Cervical cancer and HIV

    LF Tanaka, D Stelzle, SJ Klug

  • FACT SHEET: COLOMBIA www.hpvcentre.net

    V. Rangel, R. Murillo, G. Albero, L. Bruni

  • HOME
  • Published material
  • Remembering our colleagues
  • About us
  • Contact us

Login

Change email Change password Activate service

Did you forget your password?

Do you want to subscribe?

Legal noticePrivacy Policy
Copyright © 2023 HPV World All rights reserved